LIVINGSTON, NJ--(Marketwire - Oct 2, 2012) - Milestone Scientific Inc. (
Upon approval of The Wand handpiece, Milestone's exclusive Chinese distributor, China National Medicines Corporation (CNMC) will be able to commence sales of the STA System across China.
Leonard Osser, Chief Executive Officer of Milestone Scientific, commented, "This approval brings us closer to entering the Chinese market. Our agent anticipates approval on our disposable handpiece in the coming months. After three years of waiting, our STA System computer has finally been granted registration approval by the State Food and Drug Administration of the People's Republic of China."
The patented, award-winning STA System is a computer-controlled, pressure-sensitive injection system, which provides dentists with audible and visual signals as to in-tissue pressure and needle location. Milestone's latest achievement in computer-controlled local anesthesia delivery makes the injection process more comfortable for both dentists and patients and allows for the painless delivery of local anesthetic. In addition to its general use for all dental injections, the STA System is uniquely capable of predictably and more comfortably administering "Single Tooth Anesthesia" into the Periodontal Intraligamentary (PDL) space. This injection results in the patient having no collateral numbness and no pain along with instant, predictable anesthesia. The benefit of this injection with the STA instrument is significant for the patient, the dentist and the business of dentistry.
About Milestone Scientific Inc.
Headquartered in Livingston, New Jersey, Milestone Scientific is engaged in pioneering advanced computer-controlled drug delivery technologies for the medical and dental markets and currently sells its award-winning products through a global distribution network serving North and South America, Asia, Africa, Europe and the Middle East. For more information on the STA Single Tooth Anesthesia System® instrument and other innovative Milestone products, please visit the Company's web site found at www.milestonescientific.com.
This press release contains forward-looking statements regarding the timing and financial impact of Milestone's ability to implement its business plan, expected revenues and future success. These statements involve a number of risks and uncertainties and are based on assumptions involving judgments with respect to future economic, competitive and market conditions and future business decisions, all of which are difficult or impossible to predict accurately and many of which are beyond Milestone's control. Some of the important factors that could cause actual results to differ materially from those indicated by the forward-looking statements are general economic conditions, failure to achieve expected revenue growth, changes in our operating expenses, adverse patent rulings, FDA or legal developments, competitive pressures, changes in customer and market requirements and standards, and the risk factors detailed from time to time in Milestone's periodic filings with the Securities and Exchange Commission, including without limitation, Milestone's Annual Report for the year ended December 31, 2011. The forward looking-statements in this press release are based upon management's reasonable belief as of the date hereof. Milestone undertakes no obligation to revise or update publicly any forward-looking statements for any reason.